Epoxy Technology Inc. Announces Further Extension of their ISO 10993 Biocompatible Adhesive Line, adding EPO-TEK® 353ND-T, OG 198-54 and 301 to their Comprehensive Offering
(Billerica, MA) – April 8, 2015- Epoxy Technology Inc, a leading manufacturer of high performance specialty epoxy, UV & Hybrid adhesives for 49 years, is pleased to announce the successful completion of ISO 10993 testing on three additional products. This now brings the total number of biocompatible products to 20, with 9 having passed the even more stringent testing of ISO 10993.
Joan Bramer, Global Sales & Marketing Director says, “We, at Epoxy Technology, Inc., are committed to testing our products to the industry’s most comprehensive ISO10993 biocompatibility standards. These latest positive results for EPO-TEK 353ND-T, OG 198-54 and 301, which included an extended, long term implantation study of 12 weeks for 301 shows our investment in the medical industry.
EPO-TEK 353ND-T, a thixotropic variation of an established “industry standard” 353ND, is easily applied by multiple methods, has outstanding strength as well as high moisture and chemical resistance. It is well suited for all conventional sterilization methods: ETO, Sterrad®, X-ray and autoclaving.
EPO-TEK® OG198-54, a unique, one component, low viscosity, electrically & thermally insulating UV epoxy adhesive, was formulated to have added performance (shadow curing) with thermal post curing.
EPO-TEK 301, a low viscosity, low temperature cured (65C/1 hour), optically clear, two component epoxy adhesive, previously passing the standard ISO10993 testing, has now successfully passed the more extensive testing of 12 weeks implantation.
For more information please contact us!